Dedicated to finding a
cure for brain cancer

2023 Grant Awards

Applications Accepted No Earlier Than January 1, 2023

Emerging Leader Grant Award

The Ben & Catherine Ivy Foundation Emerging Leader Award provides grant support to early-to-mid-career investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support ambitious pilot projects designed to identify drug strategies appropriate for early-phase pharmacodynamic- and pharmacokinetic-driven clinical trials in partnership with the Ivy Brain Tumor Center.

Translational Adult Glioma Award

The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.

Introducing the Largest Phase 0 Clinical Trials Program in the World

The Ivy Brain Tumor Center is a nonprofit translational research program that offers state-of-the-art clinical trials for patients with aggressive brain tumors.

Play Video

PHASE 0 TRIALS

Ivy Phase 0 clinical trials allow patients to receive individualized treatment in a fraction of the time and costs associated with traditional drug research and development. This approach addresses the two most common reasons most drugs fail in brain tumor patients:

  • Most new drugs are incapable of reaching the brain.
  • Laboratory animal studies of new drugs paint an incomplete picture of how the drugs will perform in humans.

Patient Story

Dr. Patricia Tagle-Levy

When Patricia’s glioblastoma came back after her first surgery, both she and her husband knew it was time to start looking at alternative treatment options. After extensive research, they discovered the hope they were looking for was actually right in their backyard at the Ivy Brain Tumor Center in Phoenix.

Ivy Center Headquarters

Opening Fall 2023

The Ivy Brain Tumor Center is well underway on the construction of its new headquarters, the world’s largest translational research center dedicated solely to brain tumor drug development and treatment. The new building, located on the Dignity Health St. Joseph’s Hospital and Medical Center campus in Phoenix, Arizona, will be home to the Ivy Center’s scientists, investigators, clinicians and operational staff. In addition to laboratory space, the new building will house 14,000 square feet for trials infrastructure and 7,000 square feet for multidisciplinary clinical consultation, an MRI-guided ultrasound suite and a video teleconference auditorium.

  • Sanjiv Sam Gambhir M.D., Ph.D
    Now Playing
  • Ivy Foundation Honored
    Now Playing
  • The Mayo Clinic and Ivy Foundation
    Now Playing

DONATE

Donations to the Ben and Catherine Ivy Foundation can be made via check and mailed to 6710 North Scottsdale Road, #235, Scottsdale, AZ 85253

Donations to the Ivy Brain Tumor Center at Barrow Neurological Institute can be made via the link below.

A Message from Catherine Ivy

The Ivy Foundation has the long-term, ultimate goal to cure brain cancer. To that end, we fund cutting-edge research that will improve diagnostics and treatment options for patients with brain cancer. Since 2005, we’ve committed more than $135 million to brain tumor research, with the expectation that this will lead to an eventual cure. We are dedicated to this effort because funding leads to answers, and answers lead to hope.

Ivy Neurological Sciences Internship Program at TGen prepares student-scientists for the next phase of their careers.

Foundation Partners

Close Menu